{
    "clinical_study": {
        "@rank": "119331", 
        "arm_group": [
            {
                "arm_group_label": "Regimen A for AM colonoscopy", 
                "arm_group_type": "Experimental", 
                "description": "Regimen A for morning colonoscopy"
            }, 
            {
                "arm_group_label": "Regimen A for PM colonoscopy", 
                "arm_group_type": "Experimental", 
                "description": "Regimen A for afternoon colonoscopy"
            }, 
            {
                "arm_group_label": "Regimen B for AM colonoscopy", 
                "arm_group_type": "Experimental", 
                "description": "Regimen B for morning colonoscopy"
            }, 
            {
                "arm_group_label": "Regimen B for PMcolonoscopy", 
                "arm_group_type": "Experimental", 
                "description": "Regimen B for afternoon colonoscopy"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to determine the efficacy of 2 regimens of lactulose as a\n      preparation for colonoscopy."
        }, 
        "brief_title": "2 Regimens of Lactulose for Colonoscopy Preparation in Adults", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Colonoscopy Preparation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients requiring bowel evacuation for colonoscopy.\n\n        Exclusion Criteria:\n\n          -  Patients with galactosemia (galactose-sensitive diet).\n\n          -  Patients known to be hypersensitive to any of the components of lactulose for oral\n             solution.\n\n          -  Patients with an abnormality on screening blood work or vital sign assessments that,\n             in the Investigator's judgment, may pose a significant risk including those\n             pertaining to dehydration or electrolyte shifts.\n\n          -  Patients with a history of impaired renal function.\n\n          -  Patients with current or recent history of hypotension, as defined by the\n             Investigator.\n\n          -  Patients with a history of long Q-T syndrome.\n\n          -  Patients with a history of a failed bowel preparation.\n\n          -  Patients with severe constipation, defined as those patients taking daily\n             prescription or over-the-counter laxatives.\n\n          -  Patients with possible bowel obstruction, gastric retention, bowel perforation, toxic\n             colitis, toxic megacolon, ileus or previous colonic surgery.\n\n          -  Patients on lactulose therapy or receiving any treatment for chronic constipation.\n\n          -  Be pregnant or nursing.\n\n          -  Patients with known large polyps or flat polyps (i.e. polyps requiring electrocautery\n             or argon plasma coagulation).\n\n          -  Patients less than 18 years of age.\n\n          -  Inability to understand the requirements of the study or be unwilling to provide\n             written informed consent (as evidenced by signature on an informed consent document\n             approved by an Institutional Review Board [IRB]) and agree to abide by the study\n             restrictions.\n\n          -  Be otherwise unsuitable for the study, in the opinion of the Investigator."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "55", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01887470", 
            "org_study_id": "CPI-KR-004"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Regimen A for AM colonoscopy", 
                    "Regimen A for PM colonoscopy"
                ], 
                "intervention_name": "Regimen A", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Regimen B for AM colonoscopy", 
                    "Regimen B for PMcolonoscopy"
                ], 
                "intervention_name": "Regimen B", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Lactulose"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Bowel Evacuation", 
            "Colonoscopy Preparation"
        ], 
        "lastchanged_date": "March 14, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chattanooga", 
                    "country": "United States", 
                    "state": "Tennessee", 
                    "zip": "37421"
                }, 
                "name": "ClinSearch, LLC"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Randomized, Single-blind Pilot Study to Determine the Safety, Efficacy, and Patient Preference of 2 Regimens of Lactulose for Cleansing of the Colon as a Preparation for Colonoscopy in Adults", 
        "overall_official": {
            "affiliation": "ClinSearch, LLC", 
            "last_name": "Richard Krause, M.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Efficacy assessed by the physician's determination of the cleanliness of the colon using the Boston Bowel Preparation Scale (BBPS).", 
            "measure": "Efficacy of lactulose as a preparation for colonoscopy.", 
            "safety_issue": "No", 
            "time_frame": "3 hours post last consumption"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01887470"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Incidence of treatment failure", 
                "safety_issue": "No", 
                "time_frame": "3 hours post last consumption"
            }, 
            {
                "description": "Tolerability assessed by a patient questionnaire.", 
                "measure": "Tolerability of and preference for lactulose as a bowel evacuant", 
                "safety_issue": "No", 
                "time_frame": "1 day post last consumption"
            }, 
            {
                "description": "Safety determined by the incidence and severity of treatment emergent adverse events.", 
                "measure": "Safety of lactulose as a bowel evacuant", 
                "safety_issue": "Yes", 
                "time_frame": "1 day post last consumption"
            }
        ], 
        "source": "Cumberland Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cumberland Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}